01 November 2004
Transgenic animals in medicine: Integration and expression of foreign genes, theoretical and applied aspectsIgor L. Goldman, Sergei G. Kadulin, Sergei V. Razin
Med Sci Monit 2004; 10(11): RA274-285 :: ID: 11820
The production of different pharmaceutically important human proteins in the mammary gland of transgenic animals constitutes an important field of modern biotechnology. In addition, transgenic animals are used to develop suitable models of various human diseases and the possibility of using transgenic technologies to adapt pigs for xenotransplantation of their organs to humans is widely discussed. All these practical applications depend on the availability of reliable techniques to obtain transgenic animals with the necessary spectrum of transgene(s) expression. In the present review we discuss different aspects of producing transgenic animals by microinjection procedure, including both technical aspects and theoretical issues. As far as the technical aspects are concerned, special emphasis is placed on DNA preparation, microinjection timing, vectors permitting delivery of large genomic fragments, and approaches used to increase integration frequency. The molecular basis of the advantage of transgene microinjection into a male pronucleus is discussed. Finally, different strategies used to obtain polytransgenic animals are critically reviewed. In the section devoted to theoretical issues, the mechanisms of integration and molecular systems regulating transgene expression are extensively discussed. In particular, the importance of the domain-level regulatory systems is outlined and experimental approaches permitting the use of the domain-level regulatory systems of the genes encoding milk proteins are described and discussed.
Keywords: Animals, Genetically Modified - genetics, Animals, Animals, Genetically Modified - genetics, Biomedical Research, Biotechnology, Cloning, Molecular, Gene Expression - genetics, Models, Genetic, Transgenes - genetics
01 November 2021 : EditorialEditorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems During the COVID-19 Pandemic?
Med Sci Monit 2022; 28:e935299
26 November 2021 : EditorialEditorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
Med Sci Monit In Press; DOI: 10.12659/MSM.935624
08 November 2021 : Database AnalysisVirtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Cor...
Med Sci Monit In Press; DOI: 10.12659/MSM.934102
01 November 2021 : EditorialEditorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems Duri...
Med Sci Monit 2022; 28:e935299
29 Nov 2021 : Database AnalysisIntegrated Analysis of Angiogenesis-Mediated Tumor Immune Microenvironment Pattern in Hepatocellular Carcin...
Med Sci Monit In Press; DOI: 10.12659/MSM.934937
26 Nov 2021 : Clinical ResearchSerum Uric Acid Levels in Relation to Atrial Fibrillation: A Case-Control Study
Med Sci Monit In Press; DOI: 10.12659/MSM.934007
26 Nov 2021 : Database AnalysisNetwork Pharmacology Integrated Molecular Docking Revealed the Mechanism of Jianpi Yiqi Taohua Decoction Ag...
Med Sci Monit In Press; DOI: 10.12659/MSM.933537
Most Viewed Current Articles
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700